|
"Guest"
I appreciate your post and I am confused. Are you sayin that the HERA results showed a 46% response rate whereas the B arm of the N9831 trial showed a 14% response rate when Herceptin was received after ACT, thus showing a conflict in the two results? If so, has anyone been able to explain away such a dramatically different showing? I don't see any discussion of that in the article you posted.
Also, any explanation for the difference between the .5% heart problems cited in the HERA study vs. the 4% problem noted in the N9831 study (which are hugely different numbers in my mind)?
I greatly appreciate any input that people can offer. Back-up support is also very helpful as I (and I know many others who read this site) fully intend to gather together all applicable research in order to make a (hopefully) informed decision.
Thank you.
Cynthia
|